US Stock MarketDetailed Quotes

ALPX Alopexx

Watchlist
  • 5.000
  • 0.0000.00%
Trading Apr 21 09:30 ET
39.26MMarket Cap-16891P/E (TTM)

About Alopexx Company

Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA.

Company Profile

SymbolALPX
Company NameAlopexx
Issue Price5.00
Founded2019
CEOMr. Daniel R. Vlock
MarketNASDAQ
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address186 Alewife Brook Parkway,Suite 1068
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02138
Phone1-617-780-1598

Company Executives

  • Name
  • Position
  • Salary
  • Daniel R. Vlock
  • President, Chief Executive Officer and Director
  • --
  • Thomas T. Thomas
  • Chief Financial Officer
  • --
  • Dr. Gerald B. Pier
  • Chief Scientific Officer
  • --
  • Christine de los Reyes
  • Chief Business Officer and Chief Commercialization Officer
  • --
  • Peter J. Werth
  • Director
  • --
  • William W. Chin
  • Senior Strategic Advisor and Director
  • --
  • Richard M. Cohen
  • Independent Director
  • --
  • Dr. Peter K. Honig, M.D.
  • Independent Director
  • --
  • Ann L. MacDougall
  • Independent Director
  • --
  • Dr. Gail H. Cassell
  • Independent Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg